Physician profile
Katy E Gray
NPI 1144663568
$521.97
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.91 · 2020: $50.33 · 2022: $286 · 2023: $88.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $81.33 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $73.36 | 2022-2023 | |
| Abbvie INC. | $71.58 | 2022-2023 | |
| Organon LLC | $69.83 | 2022-2023 | Nexplanon |
| Avanos Medical | $57.32 | 2019-2022 | |
| Myovant Sciences INC. | $36.43 | 2022 | |
| Hologic Sales and Service, LLC | $31.42 | 2022 | |
| Convatec INC. | $20.12 | 2020 | |
| Sumitomo Pharma America, INC. | $17.45 | 2023 | Myfembree |
| Exeltis, USA INC. | $13.58 | 2022 | |
| Merck Sharp & Dohme LLC | $13.56 | 2019 | |
| Daiichi Sankyo INC. | $13.12 | 2020 | |
| Lupin INC. | $11.73 | 2019 | |
| Sage Therapeutics, LLC | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katy Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.